ConductScience.org, home

Paper41398241

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.

Li J and 5 others. BMC Neurol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. Papers, record 41398241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398241

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.
PubMed
Journal
BMC Neurol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li JJingqi
2Zhou RRuntang
3Deng JJialin
4Zhou HHonghttps://orcid.org/0000-0002-6460-3420
5Hu JJun
6Wang XXinzheng

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Parkinson DiseaseMajor topic
Sleep Wake DisordersMajor topic
Humans
Randomized Controlled Trials as Topic

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SQ2024AAA031359National Science and Technology Major ProjectPubMed
2023TP1047Innovation Platform and Talent ProgramPubMed
202218014518Scientific Research Project of Hunan Provincial Health CommissionPubMed
20224310NHYCG03Clinical Research 4310 Program of the First Affiliated Hospital of University of South ChinaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in41668031Correction: Sleep disorders in parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.https://conductscience.org/library/papers/41668031

Source PubMed

Download CSV of comments and corrections

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140066297Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease.NPJ Biol Timing Sleep2025https://conductscience.org/library/papers/40066297PubMed
236897120Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS.Ann Neurol2023https://conductscience.org/library/papers/36897120PubMed
337761265Sleep Disorders Associated with Neurodegenerative Diseases.Diagnostics (Basel)2023https://conductscience.org/library/papers/37761265PubMed
433714847
Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: a double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson's disease dementia.
Sleep Med2021https://conductscience.org/library/papers/33714847PubMed
517218758Melatonin in humans.J Physiol Pharmacol2006https://conductscience.org/library/papers/17218758PubMed
636045942Daridorexant for the Treatment of Insomnia.Health Psychol Res2022https://conductscience.org/library/papers/36045942PubMed
736660543Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.Clin Interv Aging2023https://conductscience.org/library/papers/36660543PubMed
835026228Etiologies of insomnia in Parkinson's disease - Lessons from human studies and animal models.Exp Neurol2022https://conductscience.org/library/papers/35026228PubMed
936468650Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias.J Clin Sleep Med2023https://conductscience.org/library/papers/36468650PubMed
1033754375Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.Mov Disord2021https://conductscience.org/library/papers/33754375PubMed
1137802998Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization.Transl Psychiatry2023https://conductscience.org/library/papers/37802998PubMed
1222290743Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.Mov Disord2012https://conductscience.org/library/papers/22290743PubMed
1323056363Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum.PLoS One2012https://conductscience.org/library/papers/23056363PubMed
1431674060Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial.Mov Disord2020https://conductscience.org/library/papers/31674060PubMed
1528559480In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist.J Pharmacol Exp Ther2017https://conductscience.org/library/papers/28559480PubMed
1639650051Effect of zonisamide on sleep and rapid eye movement sleep behavioral disorders in patients with Parkinson's disease: A randomized control trial.Clin Park Relat Disord2024https://conductscience.org/library/papers/39650051PubMed
1738942041Sleep and sleep disorders in people with Parkinson's disease.Lancet Neurol2024https://conductscience.org/library/papers/38942041PubMed
1823388588[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].Zh Nevrol Psikhiatr Im S S Korsakova2012https://conductscience.org/library/papers/23388588PubMed
1923890176Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson's disease.Chin Med2013https://conductscience.org/library/papers/23890176PubMed
2036503403Common Sleep Disorders Affecting Older Adults.Perm J2023https://conductscience.org/library/papers/36503403PubMed

See all 78 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42338732Parkinson's disease beyond motor symptoms: a review of the validity and limitations of current classification of non-motor symptoms.Front Psychiatry2026https://conductscience.org/library/papers/42338732PubMed
41668031Correction: Sleep disorders in parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis.BMC Neurol2026https://conductscience.org/library/papers/41668031PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41398241

GET https://conductscience.org/api/papers/v1/41398241/references?page=2